Navigation Links
UT researchers to study massive transfusion at major trauma centers

The U.S. Department of Defense has awarded The University of Texas Health Science Center at Houston a $9.2 million grant to conduct a multi-center clinical trial that could lead to an improved survival rate for trauma patients both soldiers and civilians -- who require massive blood transfusions.

The university's Center for Clinical and Translational Sciences (CCTS) is contracting with the U.S. Army Institute of Surgical Research to serve as the data coordination center for a Prospective, Observational, Multi-center Massive Transfusion Trial (PROMMTT). Clinical trial sites for the two-year study will include Memorial Hermann Texas Medical Center and at least nine other trauma centers.

"Those first few hours after injury are critical, and we'll be looking at what happens minute-to-minute that determines whether these patients live or die," said Col. John Holcomb, M.D., co-investigator, director of the Center for Translational Injury Research (CeTIR) and professor in the Department of Surgery at The University of Texas Medical School at Houston.

"This has never been done before. With these data, we'll eventually be able to pinpoint what works and what doesn't, develop standards for transfusion ratios and greatly improve the mortality rate, which currently is as high as 40 to 70 percent, depending on the trauma center. We will be able to design prospective randomized trials with quality data," Holcomb said. "Finally, what we learn in the civilian population will also benefit the military."

From the time a trauma patient is admitted to the hospital to the time of discharge or death, healthcare providers will be logging data on vital signs, units of packed red blood cells, fresh frozen plasma and platelets, as well as medications and other healthcare information.

Jiajie Zhang, Ph.D., co-investigator, holder of the Dr. Doris L. Ross Professorship and the associate dean for research at The University of Texas School of Health Information Sciences at Houston, is leading the effort to design a secure, web-based informatics system that will make it possible to collect these data by the patient's bedside. The system also will allow for subsequent data management and analysis for clinical and translational research.

Mohammad Hossein Rahbar, Ph.D., director of the CCTS's Biostatistics, Epidemiology and Research Design (BERD) Component, is the principal investigator who will establish and manage the consortium of trauma centers and coordinate the data collection, data management and statistical analysis. Deborah Del Junco, Ph.D., associate professor at the CCTS-BERD, is among the co-investigators he will work with on the project.

"It is a very ambitious, meaningful project that draws upon the talents of those who are part of the CCTS," said Rahbar, who also holds a faculty appointment at The University of Texas School of Public Health. "The findings of this study could have long-term global implications, and it will set the stage for future studies."

Peter Davies, M.D., Ph.D., the university's executive vice president of research, said, "We are delighted with the success of Dr. Rahbar and his colleagues, particularly Dr. Del Junco, in competing for this very important award. It is an outstanding example of the ways that our grant to establish the CCTS is allowing us to transform clinical and translational research at our university. In addition, with the very recent recruitment of Dr. John Holcomb to our campus and the formation of the new Center for Translational Injury Research, this PROMMTT award can serve as the foundation for an enormously exciting program of trauma research at the UT Health Science Center at Houston."


Contact: Meredith Raine
University of Texas Health Science Center at Houston

Related medicine news :

1. Duke researchers show reading can help obese kids lose weight
2. Researchers use nanoparticles to deliver treatment for brain, spinal cord injuries
3. Researchers create first model for retina receptors
4. Researchers Report Stem Cell Advance
5. ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit
6. OHSU Cancer Institute researchers study breathing during radiation
7. Satellite Healthcare Announces 2008 Norman S. Coplon Extramural Grants : Grants Foster Next-Generation Kidney Disease Researchers
8. New leukemia signal could point way to better treatment, Stanford researchers find
9. Penn researchers use honeybee venom toxin to develop a new tool for studying hypertension
10. Johns Hopkins researchers suppress hunger hormone
11. Penn researchers identify natural tumor suppressor
Post Your Comments:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: